Doctor profile · Federal record

Dr. Anna Szafran-Swietlik, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Hudson, FL

  • NPI 1780815340
  • Accepts Medicare
  • MIPS 93.3 / 100 · 2023
  • 24 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
14100 Fivay RD, Diabetes Care Center
Hudson, FL 346677180
(727) 869-7822
fax (727) 862-0934

Credentials & registration

NPPES · NUCC
NPI registered
July 2009 — 17 yrs on file
Profile last updated
June 23, 2013
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Florida #ME110592

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1780815340. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,847
Distinct HCPCS
10
Medicare allowed
$210,043
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 2,040 24 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 610 308 $127
82962 Blood glucose (sugar) test performed by hand-held instrument 361 192 $3
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 160 71 $34
99213 Established patient office or other outpatient visit, 20-29 minutes 146 104 $90
76536 Ultrasound scan of head and neck soft tissue 128 122 $109
99215 Established patient office or other outpatient visit, 40-54 minutes 99 85 $177
99204 New patient office or other outpatient visit, 45-59 minutes 94 94 $167
96372 Injection of drug or substance under skin or into muscle 73 33 $14
10005 Fine needle aspiration biopsy using ultrasound guidance, first growth 46 39 $136

In context: peer comparison

Among 4 peers in this city , average services per provider: 541. This provider delivers 7.1× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,045
Transactions
92
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novo Nordisk Inc 15 $289.89
Corcept Therapeutics 11 $227.36
Lilly USA, LLC 13 $204.74
Amgen Inc. 10 $183.27
Bayer Healthcare Pharmaceuticals Inc. 10 $179.49
SANOFI-AVENTIS U.S. LLC 7 $156.60
Dexcom, Inc. 3 $118.03
Medtronic, Inc. 1 $109.89
Xeris Pharmaceuticals, Inc. 5 $98.23
Lexicon Pharmaceuticals, Inc. 3 $78.44
BETA BIONICS, INC. 4 $65.00
RECORDATI_RARE_DISEASES_INC. 3 $62.88
Boehringer Ingelheim Pharmaceuticals, Inc. 3 $59.71
Amneal Pharmaceuticals LLC 2 $38.82
PFIZER INC. 2 $30.94

By nature of payment

Food and Beverage
$2,045

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,174
Patients
1,030
Total drug cost
$1,960,504
Drug Type Claims Patients Total cost
Ozempic (Semaglutide) Brand 567 126 $844,036
Levothyroxine Sodium Generic 518 162 $10,227
Metformin Hcl Generic 288 104 $2,232
Jardiance (Empagliflozin) Brand 231 73 $292,159
Atorvastatin Calcium Generic 220 77 $3,447
Rosuvastatin Calcium Generic 186 79 $3,963
Novolog Flexpen (Insulin Aspart) Brand 175 65 $219,198
Methimazole Generic 152 41 $2,836
Tresiba Flextouch U-100 (Insulin Degludec) Brand 152 58 $108,675
Trulicity (Dulaglutide) Brand 144 39 $236,272

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Anna Szafran-Swietlik's medical specialty?
Dr. Anna Szafran-Swietlik practices Endocrinology, Diabetes & Metabolism Physician in Hudson, FL.
Where does Dr. Anna Szafran-Swietlik practice?
Dr. Anna Szafran-Swietlik practices at 14100 Fivay RD, Hudson, FL 346677180. Office phone: 7278697822.
What is Dr. Anna Szafran-Swietlik's NPI?
Dr. Anna Szafran-Swietlik's National Provider Identifier (NPI) is 1780815340, issued by NPPES.
Does Dr. Anna Szafran-Swietlik accept Medicare assignment?
Yes. Dr. Anna Szafran-Swietlik accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Anna Szafran-Swietlik commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.